Brief: Adverum Biotechnologies- On May 18, Received Approval From Nasdaq To Transfer Listing Of Co's Common Stock Nasdaq Capital Market
19/05/2023 21:31
Adverum Biotechnologies Inc ADVM.O :
* ADVERUM BIOTECHNOLOGIES- ON MAY 18, RECEIVED APPROVAL FROM
NASDAQ TO TRANSFER LISTING OF CO'S COMMON STOCK NASDAQ CAPITAL
MARKET
* ADVERUM BIOTECHNOLOGIES INC - COMPANY'S SECURITIES WILL BE
TRANSFERRED TO CAPITAL MARKET AT OPENING OF BUSINESS ON MAY 22,
2023
Source text for Eikon: ID:
Further company coverage: ADVM.O
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)